Key result
Conscientiousness did not moderate the prospective relationship between neuroticism and the onset of hypertension (OR 0.98; 95% CI 0.95-1.01), diabetes, or heart disease.
Why the study?
Early investigations of the neuroticism by conscientiousness interaction regarding health were promising, but systematic investigations accounting for various personality instruments, populations, or aspects of health were lacking.
Does the interaction of neuroticism and conscientiousness affect the prevalence and incidence of chronic conditions?
Meta-Analysis (n=49,375)
Yes
Does the interaction of neuroticism and conscientiousness affect the prevalence and incidence of chronic conditions?
There is no evidence that healthy neuroticism (the interaction of conscientiousness and neuroticism) buffers against the prevalence or incidence of chronic conditions like hypertension, diabetes, or heart disease.
No evidence that healthy neuroticism buffers cardiometabolic risk; leaves open whether personality interactions predict hypertension, diabetes, or heart disease onset.
Early investigations of the neuroticism by conscientiousness interaction with regards to health have been promising, but to date, there have been no systematic investigations of this interaction that account for the various personality measurement instruments, varying populations, or aspects of health. The current study – the second of three – uses a coordinated analysis approach to test the impact of the neuroticism by conscientiousness interaction on the prevalence and incidence of chronic conditions. Using 15 pre-existing longitudinal studies (N > 49,375), we found that conscientiousness did not moderate the relationship between neuroticism and having hypertension (OR = 1.00,95%CI[0.98,1.02]), diabetes (OR = 1.02[0.99,1.04]), or heart disease (OR = 0.99[0.97,1.01]). Similarly, we found that conscientiousness did not moderate the prospective relationship between neuroticism and onset of hypertension (OR = 0.98[0.95,1.01]), diabetes (OR = 0.99[0.94,1.05]), or heart disease (OR = 0.98[0.94,1.03]). Heterogeneity of effect sizes was largely nonsignificant, with one exception, indicating that the effects are consistent between datasets. Overall, we conclude that there is no evidence that healthy neuroticism, operationalized as the conscientiousness by neuroticism interaction, buffers against chronic conditions.
No takes yet. Share an insight, caveat, or question.
Weston et al. (2020) conducted a meta-analysis in Chronic conditions (hypertension, diabetes, heart disease) (n=49,375). Neuroticism by conscientiousness interaction (healthy neuroticism) was evaluated on Onset of hypertension (OR 0.98, 95% CI 0.95-1.01). Conscientiousness did not moderate the prospective relationship between neuroticism and the onset of hypertension (OR 0.98; 95% CI 0.95-1.01), diabetes, or heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: